Fate Therapeutics Inc (FATE) stock
FATENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3024% below fair value
$1.02−0.12 (-10.53%)
Close on Nov 17, 2026Market cap $122.22MP/E –Yield –
Fate Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Fate Therapeutics's market cap was $187.29M on Nov 11, 2026, against $131.48M a year earlier. Over the last 5 years it ranged from $90.01M to $5.58B, with a median of $368.71M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $187.29M | +65.3% |
| 2025 | Dec 31, 2025 | $113.33M | -39.7% |
| 2024 | Dec 31, 2024 | $187.91M | -49.0% |
| 2023 | Dec 29, 2023 | $368.71M | -62.4% |
| 2022 | Dec 30, 2022 | $979.86M | -82.4% |
| 2021 | Dec 31, 2021 | $5.58B | -29.5% |
| 2020 | Dec 31, 2020 | $7.91B | +436.0% |
| 2019 | Dec 31, 2019 | $1.48B | +78.3% |
| 2018 | Dec 31, 2018 | $827.58M | +226.7% |
| 2017 | Dec 29, 2017 | $253.30M | +195.5% |
| 2016 | Dec 30, 2016 | $85.71M | -11.4% |
| 2015 | Dec 31, 2015 | $96.77M | -6.4% |
| 2014 | Dec 31, 2014 | $103.43M | +1095.5% |
| 2013 | Dec 31, 2013 | $8.65M | – |
See a number that looks wrong?